Has Mark Fletcher, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,677 in general payments to Mark Fletcher, MD across 1,056 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Fletcher, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Fletcher, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Fletcher, MD

Neurology · Tupelo, MSNPI 1225021371

Payments from drug & device makers

$40,677in general payments, 2019–2025

Across 1,056 payments — averaging $38.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$21K
AbbVie$5K
Novartis$1K
AstraZeneca$989
Teva Pharmaceuticals USA, Inc.$859
SK Life Science, Inc.$790
plus $11K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	50	$20,569
AbbVie(2 entities)	278	$5,284
Novartis	58	$1,261
AstraZeneca(2 entities)	43	$989
Teva Pharmaceuticals USA, Inc.	50	$859
SK Life Science, Inc.	32	$790
Livanova USA, Inc.	15	$784
Pfizer	47	$641
Amgen	29	$555
Acadia Pharmaceuticals Inc	29	$555
Jazz Pharmaceuticals Inc.	18	$535
UCB, Inc.	23	$531
Acorda Therapeutics, Inc	26	$512
Biohaven Pharmaceutical Holding Company Ltd.	25	$501
Biogen	21	$496
Harmony Biosciences LLC	16	$423
Genentech USA, Inc.	26	$388
Lilly USA, LLC	26	$382
Biohaven Pharmaceuticals, Inc.	22	$377
Lundbeck LLC	17	$330
EMD Serono, Inc.	15	$326
Tanabe Pharma America, Inc.	17	$317
Avanir Pharmaceuticals, Inc.	23	$313
Amneal Pharmaceuticals LLC	16	$304
Neurocrine Biosciences, Inc.	17	$300
Piramal Critical Care	13	$289
Argenx US, Inc.	9	$286
Supernus Pharmaceuticals, Inc.	22	$247
Merz Pharmaceuticals, LLC	9	$229
Medtronic(2 entities)	12	$189
Neurelis, Inc.	2	$107
Catalyst Pharmaceuticals, Inc.	5	$97
Bristol Myers Squibb	6	$92
Otsuka America Pharmaceutical, Inc.	4	$83
Alnylam Pharmaceuticals Inc.	3	$77
Greenwich Biosciences, Inc.	1	$74
CSL Behring	4	$68
Sunovion Pharmaceuticals Inc.	4	$65
Impel Pharmaceuticals Inc.	2	$55
Springworks Therapeutics, Inc.	2	$50
Merz North America, Inc.	2	$47
ANI Pharmaceuticals, Inc.	2	$42
TG Therapeutics, Inc.	2	$40
Eisai Inc.	2	$37
Corium, LLC	2	$33
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Amylyx Pharmaceuticals, Inc.	1	$21
Avion Pharmaceuticals	1	$19
Boston Scientific	1	$17
Sumitomo Pharma America, Inc.	1	$17
Averitas Pharma Inc.	1	$16
Resmed Corp	1	$15
Sanofi-aventis U.S. LLC	1	$11

How this compares

$40,677 in reported general payments places this provider in the 80th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$107,447

Medicare patients

331

Services billed

1,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Tupelo

Stephen LandyTupelo$1.9M
Justin GraffTupelo$85K
Samuel NewellTupelo$10K
Donna HarringtonTupelo$6K
William OakesTupelo$3K
Ali AhmadTupelo$2K
Esther FischerTupelo$2K
Ronald SchwartzHattiesburg$5.6M
Ruth FredericksJackson$943K
Wendell HelvestonJackson$883K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →